Stan Berenshteyn
Stock Analyst at Wells Fargo
(1.28)
# 3,675
Out of 5,093 analysts
70
Total ratings
39.02%
Success rate
-10.58%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Stan Berenshteyn
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VEEV Veeva Systems | Maintains: Overweight | $341 → $333 | $232.00 | +43.53% | 9 | Nov 25, 2025 | |
| HCAT Health Catalyst | Maintains: Overweight | $6 → $5 | $2.61 | +91.57% | 7 | Nov 11, 2025 | |
| AMWL American Well | Maintains: Overweight | $12 → $9 | $4.04 | +122.77% | 5 | Nov 5, 2025 | |
| DOCS Doximity | Maintains: Equal-Weight | $62 → $65 | $45.13 | +44.03% | 12 | Aug 8, 2025 | |
| OMCL Omnicell | Maintains: Overweight | $37 → $40 | $43.49 | -8.02% | 17 | Jul 21, 2025 | |
| TDOC Teladoc Health | Maintains: Equal-Weight | $10 → $8 | $7.70 | +3.90% | 3 | May 8, 2025 | |
| GDRX GoodRx Holdings | Maintains: Overweight | $8 → $7 | $2.70 | +159.26% | 8 | Apr 29, 2025 | |
| HQY HealthEquity | Maintains: Overweight | $110 → $125 | $93.26 | +34.03% | 9 | Feb 26, 2025 |
Veeva Systems
Nov 25, 2025
Maintains: Overweight
Price Target: $341 → $333
Current: $232.00
Upside: +43.53%
Health Catalyst
Nov 11, 2025
Maintains: Overweight
Price Target: $6 → $5
Current: $2.61
Upside: +91.57%
American Well
Nov 5, 2025
Maintains: Overweight
Price Target: $12 → $9
Current: $4.04
Upside: +122.77%
Doximity
Aug 8, 2025
Maintains: Equal-Weight
Price Target: $62 → $65
Current: $45.13
Upside: +44.03%
Omnicell
Jul 21, 2025
Maintains: Overweight
Price Target: $37 → $40
Current: $43.49
Upside: -8.02%
Teladoc Health
May 8, 2025
Maintains: Equal-Weight
Price Target: $10 → $8
Current: $7.70
Upside: +3.90%
GoodRx Holdings
Apr 29, 2025
Maintains: Overweight
Price Target: $8 → $7
Current: $2.70
Upside: +159.26%
HealthEquity
Feb 26, 2025
Maintains: Overweight
Price Target: $110 → $125
Current: $93.26
Upside: +34.03%